Good morning, ladies and gentlemen. I'm Kevin Comcowich, chairman of the board of directors of Arcadia Biosciences. It's my pleasure to welcome you to the Arcadia Biosciences Annual Meeting of Stockholders. I will act as chair of this meeting. Before proceeding further, I'd like to provide some introductions to those in attendance today. In addition to myself, with us today are directors Amy Yoder and T.J. Schaefer, who is also its president and CEO of the company and will be serving as the inspector of elections, and Greg Waller, director and nominee. Also present is Gordon MacLean from RJI International, our independent registered public accountant. I'll now turn the meeting over to T.J., the company's chief executive officer and corporate secretary, who will conduct the formal part of the meeting. Thank you, Kevin. A copy of the agenda is showing on the screen, and the rules of procedure for the meeting are available via the link below. We ask that you please observe these rules and procedures to help ensure that the business of the meeting proceeds in an orderly fashion. The proposals on the agenda for the formal meeting are as follows: The election of Gregory Waller as a Class II director. To approve, pursuant to Nasdaq Listing Rule 5635(b), the potential issuance of our common stock upon exercise of the Series A-1 preferred investment options that were sold in our private placement transaction that closed on June 12, 2026. To approve the 2026 Omnibus Equity Incentive Plan. To approve an amendment to our amended and restated certificate of incorporation to effect a reverse stock split of our outstanding shares of common stock if our Board of Directors, in its discretion, determines to effect a reverse stock split at any time before June 30, 2027, at a reverse stock split ratio ranging from one for two to one for 10, as determined by our Board of Directors at a later date. The approval on a non-binding basis of the compensation of the company's named executive officers as disclosed in the proxy statement. To ratify the appointment of Ramirez Jimenez International CPAs as our independent registered public accountants for the fiscal year ending December 31, 2026. To approve a proposal to adjourn the meeting by the chairperson of the meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are not sufficient votes in favor of the share issuance proposal or the reverse split proposal. After we vote on the matters to be considered at the meeting today, an announcement will be made regarding the preliminary results, and the formal meeting will be adjourned. If you are a stockholder and you have any questions about the proposals you'll be voting on today, you may submit them using the Q&A form on the screen. Only stockholders may ask questions, and we are only taking questions related to the business of the annual meeting today. I have proof by affidavit that notice of this meeting has been duly given and that the notice of this meeting and an accompanying proxy statement and annual report were first all stockholders of record at the close of business on July 29, 2026, the record date for the meeting. We have at this meeting a record of stockholders as of that date. We have present in person or by proxy a sufficient number of shares to constitute a quorum. Therefore, the meeting is duly constituted, and we may proceed with business. We will vote by proxy or by online ballot. Each holder of Arcadia common stock is entitled to one vote for each share of common stock held at the close of business on the record date. If you have previously submitted your proxy and you do not intend to change your vote, it is not necessary that you vote online. Your vote will be counted. If you are eligible to vote and have not submitted your proxy, or if you want to change your vote, please vote online at the indicated time for voting. The votes cast today will be counted in the final tally, along with the proxies previously received. It is now 1:04 P.M. Central Time on September 10, 2026, and the polls for each matter to be voted on at this meeting are now open. Pursuant to the proxy materials, the proxies solicited by the board of directors will be voted in favor of each of the proposals described below. The first proposal is the election of one Class II director. The director elected at today's meeting will hold office until the 2029 annual meeting of stockholders or until his successor is duly elected and qualified. As indicated in the company's proxy statement, Gregory Waller has been nominated by the board of directors to serve as the Class II director. The company's bylaws require that a stockholder provide advance notice to the company of a stockholder's intent to nominate persons as directors. No such notice was received. Accordingly, I declare the nominations for directors closed. Are there any questions regarding this proposal? Those of you who are voting online should now complete your vote on this proposal. The second proposal is to approve, pursuant to Nasdaq Listing Rule 5635(b), the potential issuance of our common stock upon exercise of the Series A-1 preferred investment options that were sold in our private placement transaction that closed on June 12, 2026. Are there any questions regarding this proposal? Those of you who are voting online should now complete your vote on this proposal. The third proposal is to approve the 2026 Omnibus Equity Incentive Plan. Are there any questions regarding this proposal? Those of you who are voting online should now complete your vote on this proposal. The fourth proposal is to approve an amendment to our amended and restated certificate of incorporation to effect reverse stock split of our outstanding shares of common stock if our board of directors, in its discretion, determines to effect a reverse stock split at any time before June 30, 2027, at a reverse stock split ratio ranging from one for two to one for 10. Are there any questions regarding this proposal? Those of you who are voting online should now complete your vote on this proposal. The fifth proposal is to approve the compensation of our named executive officers as described in the company's proxy statement for this meeting. This proposal is a non-binding stockholder advisory vote. Are there any questions regarding the proposal? Those of you who are voting online should now complete your vote on this proposal. The sixth proposal is to ratify the appointment of Ramirez Jimenez International CPAs as independent auditors for the company for the fiscal year ending December 31st, 2026. Gordon MacLean is present from RJI and is available to answer any appropriate questions that you have at this time. Are there any questions regarding the proposal? Those of you who are voting online should now complete your vote on this proposal. The seventh proposal is a proposal to adjourn this meeting by the chair of the meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are not sufficient votes in favor of the issuance proposal or the reverse split proposal. Are there any questions regarding the proposal? Those of you who are voting online should now complete your vote on this proposal. It is now approximately 1:09 P.M. Central Time on September 10th, 2026, and the polls for each matter to be voted on at this meeting are now closed. No additional votes and no changes or revocations will be accepted. We will now tabulate the votes and provide a preliminary report on the voting results. Based upon preliminary information, I can report that with regard to proposal one, Gregory Waller has been elected to the board to serve as a Class II director. With regard to proposal two, the issuance proposal has been approved by a majority of the votes cast affirmatively or negatively. With regard to proposal three, the 2026 Omnibus Equity Incentive Plan has been approved by a majority of the votes cast affirmatively or negatively. With regard to proposal four, the reverse split proposal has been approved by a majority of the votes cast affirmatively or negatively. With regard to proposal five, the compensation of the company's executive officers has been approved by a majority of the votes cast affirmatively or negatively. With regard to proposal six, the appointment of Ramirez Jimenez International CPAs to act as the company's independent auditor for the fiscal year ending December 31st, 2026, has been ratified by a majority of the votes cast affirmatively or negatively. With regard to proposal seven, the adjournment proposal has been approved by a majority of the votes cast affirmatively or negatively. These are the preliminary results of voting. The final results of voting will be set forth in the minutes of the meeting and will be included in our reports filed with the SEC. We did not receive any questions from stockholders, and this annual meeting of stockholders is now adjourned. Thank you for your attendance. I will now turn the meeting over to Kevin. Thank you, T.J.. I want to thank all of you for attending today's meeting and for your interest you've shown in Arcadia Biosciences. We very much appreciate your attendance, and as always, thank you for your support. The meeting has now concluded. Thank you for joining, and have a pleasant day.